Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CEACAM5 expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

CEACAM5 overexpression (4)

CEACAM5 positive (3)

CEACAM5 underexpression + MSI-H/dMMR (2)

CEACAM5 overexpression (4)

CEACAM5 positive (3)

CEACAM5 underexpression + MSI-H/dMMR (2)

›

CEACAM5 expression	Lung Non-Squamous Non-Small Cell Cancer	CEACAM5 expression	Lung Non-Squamous Non-Small Cell Cancer	SAR408701 Sensitive: C2 – Inclusion Criteria SAR408701 Sensitive : C2	SAR408701 Sensitive: C2 – Inclusion Criteria SAR408701 Sensitive : C2
CEACAM5 expression	Gastric Cancer	CEACAM5 expression	Gastric Cancer	SAR408701 Sensitive: C2 – Inclusion Criteria SAR408701 Sensitive : C2	SAR408701 Sensitive: C2 – Inclusion Criteria SAR408701 Sensitive : C2
CEACAM5 expression	Solid Tumor	CEACAM5 expression	Solid Tumor	SAR408701 Sensitive: C2 – Inclusion Criteria SAR408701 Sensitive : C2	SAR408701 Sensitive: C2 – Inclusion Criteria SAR408701 Sensitive : C2
CEACAM5 expression	Neuroendocrine Tumor	CEACAM5 expression	Neuroendocrine Tumor	IMMU-130 Sensitive: D – Preclinical IMMU-130 Sensitive : D	IMMU-130 Sensitive: D – Preclinical IMMU-130 Sensitive : D
CEACAM5 expression	Pancreatic Cancer	CEACAM5 expression	Pancreatic Cancer	SAR408701 Sensitive: D – Preclinical SAR408701 Sensitive : D	SAR408701 Sensitive: D – Preclinical SAR408701 Sensitive : D
CEACAM5 expression	Solid Tumor	CEACAM5 expression	Solid Tumor	BDC-2034 Sensitive: D – Preclinical BDC-2034 Sensitive : D	BDC-2034 Sensitive: D – Preclinical BDC-2034 Sensitive : D
CEACAM5 expression	Prostate Cancer	CEACAM5 expression	Prostate Cancer	IMMU-130 Sensitive: D – Preclinical IMMU-130 Sensitive : D	IMMU-130 Sensitive: D – Preclinical IMMU-130 Sensitive : D